Genus on track for full-year

published 10 November 2011

Animal genetics group Genus has continued to trade in line with expectations during the four months to 31 October.

The firm believes world agricultural markets have generally remained favourable for its customers and remains confident that its expectations for the full year will be met.

Adjusted operating profit continued to grow as expected, although this was partly offset by higher research and development (R&D) costs. The R&D costs were higher in part due to increased investment and slightly higher feed costs, while finance costs were lower.